This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: University of Massachusetts. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Craig Martin in RNA Synthesis
Introduction
Craig Martin is a notable inventor based in Amherst, MA (US), recognized for his contributions to the field of RNA synthesis. He holds 2 patents that focus on enzymatic methods to generate high yields of sequence-specific RNAs with extreme precision. His work has significant implications for biotechnology and molecular biology.
Latest Patents
Craig Martin's latest patents include innovative methods for producing sequence-specific RNA oligonucleotides. One patent describes synthetic methods that eliminate impurities produced in prior art methods. In this method, a first amplification primer includes one or more deoxyuridine residues, with at least one positioned in the promoter region for the single-subunit, DNA-dependent RNA polymerase. The deoxyuridines are excised to provide an amplified functional template DNA, which is then used to synthesize RNA with reduced immunogenic double-stranded RNA compared to controls. Another patent outlines methods that utilize an end-protected capture DNA complementary to a portion of the product RNA. This method also explores linking the template DNA to the RNA polymerase and employing a flow chamber, allowing for versatile applications in RNA synthesis.
Career Highlights
Craig Martin is affiliated with the University of Massachusetts, where he continues to advance research in RNA technologies. His innovative approaches have garnered attention in the scientific community, contributing to the understanding and application of RNA synthesis.
Collaborations
Craig has collaborated with notable colleagues, including Elvan Cavac and Kithmie Harshana Malagodapathiranage. Their combined expertise enhances the research output and innovation in their field.
Conclusion
Craig Martin's work in enzymatic methods for RNA synthesis represents a significant advancement in biotechnology. His patents reflect a commitment to improving the precision and efficiency of RNA production, which is crucial for various applications in research and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile